The Cost of New Oral Anti-Diabetic Drugs in Canada and Internationally

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.04.525
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cost Analysis Study of Anti-Diabetic Fixed Dose Combination Drugs: An Indian Scenario

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Joint Effects of Diabetic-Related Genomic Loci on the Therapeutic Efficacy of Oral Anti-Diabetic Drugs in Chinese Type 2 Diabetes Patients

Scientific Reports
Multidisciplinary
2016English

Medicinal Chemistry of Novel Anti-Diabetic Drugs

Open Medicinal Chemistry Journal
Drug DiscoveryMolecular MedicinePharmacologyPharmaceutical Science
2011English

Delays in the Submission of New Drugs in Canada

CMAJ
Medicine
2014English

Commentary: Advances in the Pharmacotherapy of NASH-anti-diabetic Drugs and Beyond

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Safety and Efficacy of the Available Oral Anti Diabetic Drugs in Treating Type II Diabetics During Ramadan Fasting in Sohag Governorate.

Sohag Medical Journal
2017English

Oral Antibiotics in the Nineties New Drugs and New Challenges in Primary Care

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
1997English

How Cost-Effective Are New Cancer Drugs in the U.S.?

Expert Review of Pharmacoeconomics and Outcomes Research
MedicineHealth PolicyPharmacology
2020English

The Effects of Anti-Diabetic Drugs on LDL Subclasses: Any Role for Colesevelam?

Cardiovascular Drugs and Therapy
MedicineCardiovascular MedicinePharmacologyCardiology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy